NRx Pharmaceuticals Ownership | Who Owns NRx Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

NRx Pharmaceuticals Ownership Summary


NRx Pharmaceuticals is owned by 5.23% institutional investors, 9.77% insiders, and 85.00% retail investors. Anson funds management lp is the largest institutional shareholder, holding 11.29% of NRXP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.62% of its assets in NRx Pharmaceuticals shares.

NRXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNRx Pharmaceuticals5.23%9.77%85.00%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Anson funds management lp2.03M11.29%$6.68M
Vanguard group729.84K3.28%$1.98M
Commonwealth equity services366.63K1.65%$993.57K
Advisorshares investments328.00K1.48%$888.89K
Geode capital management218.87K0.98%$593.21K
Bleakley financial group117.20K0.53%$317.62K
State street76.28K0.43%$251.74K
Blackrock funding, inc. /de82.65K0.37%$223.99K
Two sigma investments, lp52.33K0.29%$172.70K
Global retirement partners39.30K0.18%$106.50K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Anson funds management lp2.03M0.61%$6.68M
Advisorshares investments328.00K0.15%$888.89K
One wealth management investment & advisory services37.87K0.11%$102.64K
Bleakley financial group117.20K0.01%$317.62K
Ethos financial group11.90K0.00%$32.25K
Global retirement partners39.30K0.00%$106.50K
Chicago partners investment group33.42K0.00%$72.52K
Commonwealth equity services366.63K0.00%$993.57K
Two sigma investments, lp52.33K0.00%$172.70K
Sbi securities2.50K0.00%$6.78K

Top Buyers

HolderShares% AssetsChange
Anson funds management lp2.03M0.61%420.13K
Commonwealth equity services366.63K0.00%366.63K
Vanguard group729.84K-194.89K
Bleakley financial group117.20K0.01%117.20K
Global retirement partners39.30K0.00%39.30K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp---189.14K
Ubs group3.54K--149.31K
Renaissance---128.18K
Squarepoint ops---42.20K
Jane street group38.06K--35.33K

New Positions

HolderShares% AssetsChangeValue
Commonwealth equity services366.63K0.00%366.63K$993.57K
Bleakley financial group117.20K0.01%117.20K$317.62K
Global retirement partners39.30K0.00%39.30K$106.50K
Steward partners investment advisory1.00-1.00$3.00

Sold Out

HolderChange
Carolina wealth advisors-50.00
Simplex trading-690.00
Raymond james financial-2.57K
Group one trading-3.11K
Townsquare capital-15.04K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202510-62.96%1,162,134-70.63%51.07%3-83.33%3-
Sep 30, 20258-65.22%961,561-66.82%51.72%5-64.29%1-66.67%
Jun 30, 2025258.70%2,994,36832.46%189.62%1550.00%4-33.33%
Mar 31, 202523-14.81%2,260,524115.57%1313.86%10-37.50%6200.00%
Dec 31, 20242728.57%1,048,64246.80%923.53%1677.78%2-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv517.04K1.62%103.77K
Vanguard US Total Market Shares ETF193.42K1.23%-
AdvisorShares Psychedelics ETF370.47K1.16%-
Vanguard Institutional Extnd Mkt Idx Tr179.91K0.56%-
Fidelity Extended Market Index107.80K0.34%21.32K
KoAct US Brain Treatment Active41.02K0.26%41.02K
iShares Micro-Cap ETF55.05K0.17%55.05K
Mandarine Global Microcap G EUR40.00K0.13%-
Fidelity Total Market Index30.81K0.10%-
Spartan Extended Market Index Pool E14.99K0.10%6.13K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 17, 2024Javitt Jonathan C Chairman and Chief ScientistBuy$46.80K
Aug 30, 2023Gorovitz Aaron-Buy$11.20K
Aug 30, 2023Hurvitz Chaim-Buy$20.13K
Aug 23, 2023Javitt Jonathan C Chief ScientistBuy$33.00K
Aug 22, 2023Javitt Jonathan C Chief ScientistBuy$64.40K

Insider Transactions Trends


DateBuySell
2024 Q41-
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q34-

NRXP Ownership FAQ


Who Owns NRx Pharmaceuticals?

NRx Pharmaceuticals shareholders are primarily institutional investors at 5.23%, followed by 9.77% insiders and 85.00% retail investors. The average institutional ownership in NRx Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which NRx Pharmaceuticals falls below.

Who owns the most shares of NRx Pharmaceuticals?

NRx Pharmaceuticals’s largest shareholders are Anson funds management lp (2.03M shares, 11.29%), Vanguard group (729.84K shares, 3.28%), and Commonwealth equity services (366.63K shares, 1.65%). Together, they hold 16.22% of NRx Pharmaceuticals’s total shares outstanding.

Does Blackrock own NRx Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of NRx Pharmaceuticals.

Who is NRx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Anson funds management lp is NRx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.61% of its assets in 2.03M NRx Pharmaceuticals shares, valued at 6.68M$.

Who is the top mutual fund holder of NRx Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of NRx Pharmaceuticals shares, with 1.62% of its total shares outstanding invested in 517.04K NRx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools